Literature DB >> 1558096

Ketorolac-induced acute renal failure.

L A Boras-Uber, N C Brackett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1558096     DOI： 10.1016/0002-9343(92)90283-h

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  5 in total

Review 1.  Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management.

Authors:  J C Gillis; R N Brogden
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 2.  Nonsteroidal anti-inflammatory drugs and acute renal failure in the elderly. A risk-benefit assessment.

Authors:  W Ailabouni; G Eknoyan
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

3.  Haemolytic uraemic syndrome during treatment with ketorolac trometamol.

Authors:  M L Randi; T Tison; G Luzzatto; A Girolami
Journal:  BMJ       Date:  1993-01-16

4.  Plasma prostaglandin E2 concentrations after single dose administration of ketorolac tromethamine (Toradol) in dogs.

Authors:  K Pasloske; J Burger; P Conlon
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

Review 5.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.